July 15, 2005HepatologyOpen Access

Circulatory dysfunction in NAFLD — Which is first, which is last, and what do we do in between?†‡

Q: What is the clinical evidence from this study?

Study design: Editorial. Population: Nonalcoholic fatty liver disease (NAFLD). Intervention: Nonalcoholic fatty liver disease vs. Age and gender matched controls. Primary outcome: Endothelial dysfunction and 10-year probability of cardiovascular events.

View Full Paper

Ask AI

Bookmark

Key result

Nonalcoholic fatty liver disease is associated with endothelial dysfunction and an increased 10-year probability of cardiovascular events compared to matched controls.

Design

Editorial

Authors

DMDavid D. McPhersonThe University of Texas Health Science Center at Houston

Discussion

Member takes

Implication

Patients with NAFLD have a high prevalence of endothelial dysfunction and increased 10-year cardiovascular risk, necessitating aggressive management of metabolic and atherosclerotic risk factors.

PICO

Population

Nonalcoholic fatty liver disease (NAFLD)

Exposure / Comparator

Nonalcoholic fatty liver disease vs Age and gender matched controls

Primary Outcome

Endothelial dysfunction and 10-year probability of cardiovascular events

Patients with NAFLD have a high prevalence of endothelial dysfunction and increased 10-year cardiovascular risk, necessitating aggressive management of metabolic and atherosclerotic risk factors.

Cite This Study

David D. McPherson (2005) conducted an editorial in Nonalcoholic fatty liver disease (NAFLD). Nonalcoholic fatty liver disease vs. Age and gender matched controls was evaluated on Endothelial dysfunction and 10-year probability of cardiovascular events. Nonalcoholic fatty liver disease is associated with endothelial dysfunction and an increased 10-year probability of cardiovascular events compared to matched controls.

synapsesocial.com/papers/6a973807130fbb8d663c06bc https://doi.org/10.1002/hep.20834

View Full Paper

Ask AI

Bookmark

Implication

Patients with NAFLD have a high prevalence of endothelial dysfunction and increased 10-year cardiovascular risk, necessitating aggressive management of metabolic and atherosclerotic risk factors.

Circulatory dysfunction in NAFLD — Which is first, which is last, and what do we do in between?†‡

Discussion

Member takes

Implication

PICO

Cite This Study

Circulatory dysfunction in NAFLD — Which is first, which is last, and what do we do in between?†‡

Discussion

Member takes

Implication

PICO

Cite This Study

Also Consider

Also Consider